Table 1 Comparison of Variables between EAOC and OEM groups
Variable | EAOC | OEM | P | OR | 95% CI |
|---|---|---|---|---|---|
Total | 30 | 1008 | |||
Age | |||||
Mean ± SD(y) | 50.8 ± 4.1 | 48.5 ± 3.9 | .002 | ||
Range(y) | 45–59 | 45–80 | |||
<50y [n (%)] | 13 (43.3%) | 738 (73.2%) | <.001 | 3.57 | 1.71–7.46 |
≥ 50y [n (%)] | 17 (56.7%) | 270 (26.8) | |||
Menarche age, y | .987 | ||||
Mean ± SD(y) | 13.9 ± 1.4 | 13.9 ± 1.6 | |||
Range(y) | 11–17 | 10–23 | |||
Menopausal status [n (%)] | <.001 | 5.50 | 2.54–11.90 | ||
YES | 11 (36.7) | 96 (9.5) | |||
No | 19 (63.3) | 912 (90.5) | |||
Gravidity(times) | |||||
Mean ± SD | 2.3 ± 1.2 | 2.2 ± 1.3 | 0.671 | ||
Range(y) | 0–5 | 0–7 | |||
0 | 2 (6.7) | 55 (5.5) | |||
1 | 3 (10.0) | 250 (24.8) | |||
2 | 11 (36.7) | 313 (31.1) | |||
≥ 3 | 11 (36.7) | 381 (37.8) | |||
Unknown | 3 (10.0) | 9 (0.9) | |||
Parity (times) | .963 | ||||
Mean ± SD | 1 ± 0.4 | 1 ± 0.5 | |||
Range(y) | 0–2 | 0–4 | |||
0 | 2 (6.7) | 98 (9.7) | |||
1 | 26 (86.7) | 812 (80.6) | |||
2 | 2 (6.6) | 89 (8.8) | |||
≥ 3 | 0 (0) | 7 (0.7) | |||
Unknown | 0 (0) | 2 (0.2) | |||
Main symptoms [n (%)] | |||||
Pelvic mass incidentally found | 10 (33.3) | 342 (33.9) | 1.000 | ||
Dysmenorrheaa | 1 (3.3) | 293 (29.1) | .011 | 0.12 | 0.02–0.88 |
Irregular abdominal pain | 13 (43.3) | 186 (18.5) | .001 | 3.38 | 1.61–7.08 |
Irregular menstruation/ Abnormal vaginal bleeding | 5 (16.7) | 147 (14.6) | .792 | ||
Others | 1 (3.3) | 40 (4.0) | .860 | ||
Ca125 before surgery(U/mL) Number[n (%)] 27(90)779(77.3) | |||||
Median, IQR | 57.1, 32.7 ~ 168.4 | 55.9, 24.6 ~ 78.4 | .091 | ||
Range | 11–1468 | 0.5–4736 | |||
<35 | 9 (33.3) | 358 (46.0) | .240 | ||
≥ 35 | 18 (66.7) | 421 (54.0) | |||
Tumor sizeb (cm) | |||||
Number[n (%)] | 29(96.7) | 933(92.6) | |||
Mean ± SD | 8.5 ± 4.3 | 5.4 ± 2.9 | .001 | ||
Range | 3–20 | 1–30 | |||
<8 cm | 11 (37.9) | 760 (81.5) | <.001 | 7.19 | 3.34–15.50 |
≥ 8 cm | 18 (62.1) | 173 (18.5) | |||
Coexisting myoma or adenomyosis [n (%)] | 1.000 | ||||
Yes | 21 (70.0) | 688 (68.3) | |||
No | 9 (30.0) | 320 (31.7) | |||
Coexisting endomentrium disorders [n (%)] | .003 | 4.11 | 1.73–9.73 | ||
Number[n (%)] | 28 (93.3) | 665(66) | |||
Yes | 8 (28.6) | 59 (8.9) | |||
No | 20 (71.4) | 606 (91.1) | |||